| Literature DB >> 26664958 |
Abstract
Although deafness can be acquired throughout an animal's life from a variety of causes, hereditary deafness, especially congenital hereditary deafness, is a significant problem in several species. Extensive reviews exist of the genetics of deafness in humans and mice, but not for deafness in domestic animals. Hereditary deafness in many species and breeds is associated with loci for white pigmentation, where the cochlear pathology is cochleo-saccular. In other cases, there is no pigmentation association and the cochlear pathology is neuroepithelial. Late onset hereditary deafness has recently been identified in dogs and may be present but not yet recognized in other species. Few genes responsible for deafness have been identified in animals, but progress has been made for identifying genes responsible for the associated pigmentation phenotypes. Across species, the genes identified with deafness or white pigmentation patterns include MITF, PMEL, KIT, EDNRB, CDH23, TYR, and TRPM1 in dog, cat, horse, cow, pig, sheep, ferret, mink, camelid, and rabbit. Multiple causative genes are present in some species. Significant work remains in many cases to identify specific chromosomal deafness genes so that DNA testing can be used to identify carriers of the mutated genes and thereby reduce deafness prevalence.Entities:
Keywords: EDNRB; KIT; MITF; PMEL; cochlea; merle; piebald; pigmentation
Year: 2015 PMID: 26664958 PMCID: PMC4672198 DOI: 10.3389/fvets.2015.00029
Source DB: PubMed Journal: Front Vet Sci ISSN: 2297-1769
Classification and examples of different types of peripheral deafness.
| Sensorineural | Conductive | |||
|---|---|---|---|---|
| Congenital | Late onset | Congenital | Late onset | |
| Hereditary | Pigment-associated (CS) | Border collie, Rhodesian ridgeback | None known | Primary secretory otitis media |
| Acquired | Perinatal anoxia | Ototoxin exposure – gentamicin | Ear canal atresia | Otitis externa |
.
.
Resource Web sites with hereditary deafness content.
| Web page name | URL |
|---|---|
| Hereditary Hearing Loss Homepage | |
| Online Mendelian Inheritance in Man | |
| Online Mendelian Inheritance in Animals | |
| Hereditary Hearing Impairment in Mice | |
| Deafness Gene Mutation Database | |
| Connexins and Deafness Homepage | |
| HUGO Gene Nomenclature Committee | |
| OMA (“Orthologous MAtrix”) Browser | |
| International Federation of Pigment Cell Societies – Color Genes | |
| International Mouse Phenotyping Consortium | |
| Mouse Genome Informatics | |
| HomoloGene | |
| Deafness in Dogs and Cats |
Naming conventions for deafness genes and loci in humans.
| Non-syndromic genes and loci | |
|---|---|
| • Autosomal dominant (AD) – DFNA | |
| • Autosomal recessive (AR) – DFNB | |
| • X-linked – DFNX | |
| • Y-linked – DFNY | |
| • AUNA (auditory neuropathy autosomal dominant) – AUNA | |
| • Alport – COL4A5 | • X-linked or AR – collagenopathy, kidney disease, eye abnormalities |
| • Branchio-oto-renal – BOR | • AD – hypoplastic kidney and neck/preauricular pits or absence of pinna |
| • Jervell & Lange-Nielsen – JLNS | • AR – long QT syndrome |
| • Neurofibromatosis Type II – NFII | • AD – neural tissue tumors, pigmentation disorders |
| • Norrie – NDP | • X-linked recessive – blindness |
| • Pendred – PDS | • AR – goiter and hypothyroidism |
| • Stickler – STL | • AD – 2 or 3 forms – progressive arthro-ophthalmopathy, collagenopathy, facial abnormalities, joint problems |
| • Treacher Collins – TCOF or POLR | • AD – craniofacial abnormalities |
| • Usher – USH | • AR – 3 forms – progressive visual impairment from retinitis pigmentosa |
| • Waardenburg – WS | • AD or AR – 9 forms – pigmentation and neural crest defects |
| • Syndromic – MTTL | |
| • Non-syndromic – MTRN, MTTS | |
Figure 1Structures within the cochlea associated with the expression of genes identified to be causative for deafness. GJB2 is only expressed in regions 3–11 and 18. CDH23 is only expressed in regions 1, 2, and 15. Reproduced with permission from Van Camp and Smith (51).
Major Mendelian pigmentation loci and associated genes and phenotypes in dogs and cats.
| Locus/category | Gene | Allele | Phenotype |
|---|---|---|---|
| Solid coat (no spotting, wild type) | |||
| Irish spotting pattern | |||
| Piebald spotting pattern | |||
| Extreme white spotting pattern | |||
| Unknown | |||
| Ticking in white areas | |||
| No ticking (wild type) | |||
| Merle pattern | |||
| Non-merle (wild type) | |||
| Black – no dilution of eumelanin (wild type) | |||
| Liver, brown, chocolate – diluted eumelanin | |||
| Unknown | |||
| No dilution of pheomelanin (yellow, sable, fawn, wild type) | |||
| Dilution of pheomelanin (white, cream) | |||
| Harlequin pattern (in a merle background) | |||
| Merle pattern (in a merle background) | |||
| Unknown | |||
| Large smooth patches (in a merle background) | |||
| Small, jagged patches (in a merle background, wild type) | |||
| Yellow, sable, fawn | |||
| Agouti-banded hair, light colored ventrum | |||
| Black-and-tan | |||
| Recessive black | |||
| Black | |||
| Brindle (black and yellow stripes) | |||
| Wild type (allows expression of Agouti phenotypes) | |||
| Melanistic mask | |||
| Extension, wild type | |||
| Recessive yellow | |||
| White coat | |||
| High degree of spotting | |||
| Low degree of spotting | |||
| Solid (wild type) | |||
| No dilution of eumelanin (black, wild type) | |||
| Chocolate | |||
| Cinnamon | |||
| No dilution of melanin (yellow, sable, fawn) | |||
| Burmese (temperature-sensitive dilution pattern, pointed coat) | |||
| Siamese (temperature-sensitive dilution pattern, extreme pointed coat) | |||
| Albino | |||
| Agouti-banded hair (wild type) | |||
| Recessive black | |||
| Extension (wild type) | |||
| Amber, age-dependent fading of tabby pattern | |||
Modified from Schmutz and Berryere (.
.
Figure 2Modulation of . The promoter region of MITF can be modified by PAX3, SOX10, TCF, LEF-1, and CREB; TCF and LEF-1 are activated by β catenin from Wnt activation of the FZD receptor and CREB is activated by cAMP from MC1R activation by αMSH. EDNRB, activated by Edn3 and KIT activated by KITLG, act on the MAPK pathway to influence posttranslational Mitf function. Modified from Price and Fisher (63).